Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine Artesunate Granules vs Coartem in Infants with Malaria
NCT00541385Phase 3Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, open-label trial of artesunate + pyronaridine in Plasmodium falciparum malaria (2 arms), sponsored by Medicines for Malaria Venture. Primary endpoint: Percentage of Participants With PCR-Corrected Adequate Clinical and Parasitological Cure Rate at Day 28. Started Oct 2007; status: completed.
02
Drugs
artesunate + pyronaridine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00541385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541385.